Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease
Francesc Formiga,Rafael Moreno-Gónzalez,Andrea Corsonello,Francesco Mattace-Raso,Axel C Carlsson,Johan Arnlov,Joanna Kostka,Ellen Freiberger,Regina Roller-Wirnsberger,Lisanne Tap,Bartlomiej K Soltysik,Rada Artzi-Medvedik,Robert Kob,Ilan Yehoshua,Gerhard H Wirnsberger,Paolo Fabbietti,Fabrizia Lattanzio,David Chivite,Axel C. Carlsson,Johan Ärnlöv,Bartłomiej K. Sołtysik,Gerhard H. Wirnsberger,
DOI: https://doi.org/10.1159/000536465
2024-03-07
Gerontology
Abstract:Introduction: Sarcopenia, heart failure (HF), and chronic kidney disease (CKD) are common among the older people. Our objective was to evaluate the frequency of sarcopenia, among community-dwelling older adults with HF, possible causative factors, and the additive factor of CKD. Methods: A cross-sectional analysis of 1,420 older people living in the community was carried out. Participants (aged 75 years and more) came from a European multicenter prospective cohort (SCOPE study). Global geriatric assessment including short physical performance battery, handgrip strength test, and bioelectrical impedance analysis was performed. Previous known HF was defined as physician-diagnosed HF registered in the patient’s medical record or the use of HF-related medications, regardless of left ventricular ejection fraction (LVEF). Sarcopenia was defined by the updated criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). Estimated glomerular filtration rate was calculated using Berlin Initiative Study (BIS) to define the stages of CKD. Two-year mortality was also collected. Results: A total of 226 (15.9%) participants had a prior chronic HF diagnosis, with a median age of 80.0 (5.0), and 123 (54.4%) were women. Using EWGSOP2 definition, 11.5% HF and 10.7% in non-HF participants met diagnostic criteria for sarcopenia. In multivariate analyses, only a lower body mass index (BMI) (odds ratios [OR], 0.82; 95% confidence interval [CI], 0.73–0.93) and lower short physical performance battery score (OR, 0.81; 95% CI, 0.69–0.96) were associated with sarcopenia. Patients with HF and sarcopenia have a similar all-cause mortality risk but higher 2-year cardiovascular mortality risk ( p = 0.047). Discussion/Conclusion: One out of ten community-dwelling older adults with concurrent clinical stable chronic HF, without considering LVEF, have sarcopenia. Lower BMI and poor physical performance are associated with sarcopenia in this population, but not CKD.
geriatrics & gerontology,gerontology